BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
QuintilesIMS
Express Scripts
Harvard Business School
Citi
Colorcon
Merck
Cantor Fitzgerald
Argus Health
McKesson

Generated: January 21, 2018

DrugPatentWatch Database Preview

SODIUM PHENYLACETATE AND SODIUM BENZOATE Drug Profile

« Back to Dashboard

Which patents cover Sodium Phenylacetate And Sodium Benzoate, and what generic alternatives are available?

Sodium Phenylacetate And Sodium Benzoate is a drug marketed by Ailex Pharms Llc, Maia Pharms Inc, and Navinta Llc. and is included in three NDAs.

The generic ingredient in SODIUM PHENYLACETATE AND SODIUM BENZOATE is sodium benzoate; sodium phenylacetate. There are one thousand four hundred and fifteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the sodium benzoate; sodium phenylacetate profile page.
Summary for SODIUM PHENYLACETATE AND SODIUM BENZOATE
Drug patent expirations by year for SODIUM PHENYLACETATE AND SODIUM BENZOATE
Pharmacology for SODIUM PHENYLACETATE AND SODIUM BENZOATE

US Patents and Regulatory Information for SODIUM PHENYLACETATE AND SODIUM BENZOATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ailex Pharms Llc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 207096-001 Feb 24, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Maia Pharms Inc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 208521-001 May 8, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Navinta Llc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 205880-001 Aug 4, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Queensland Health
Johnson and Johnson
Baxter
Chubb
QuintilesIMS
Accenture
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot